Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
JAMA Internal Medicine|September 9, 2015
Overdiagnosis of Clostridium difficile Infection in the Molecular Test EraChristopher R Polage, Clare E Gyorke, Michael A Kennedy, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2008
Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagoguesAndrés S Hernández, Stephen G Swartz, Dorothy Slusarchyk, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
2-hydroxy-N-arylbenzenesulfonamides as ATP-citrate lyase inhibitorsJames J Li, Haixia Wang, Joseph A Tino, et al.
Bioorganic & Medicinal Chemistry Letters|September 18, 2007
Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagoguesAndrés S Hernández, Peter T W Cheng, Christa M Musial, et al.
Plos One|June 24, 2021
SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC DavisDavid A Coil, Timothy Albertson, Shefali Banerjee, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chainJun Li, Stephanie Y Chen, Shiwei Tao, et al.
Pageof 10